drugset / Trial / NCT01394913

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

NCT01394913

Phase 3 Withdrawn EMS
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a comparison of safety and efficacy of two etanercept regimens (REUMATOCEPT® versus ENBREL®) for treatment of Rheumatoid Arthritis.

Timeline

Start
2013-08
Primary completion
2014-03
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Etanercept Protein / enzyme biologic 50 mg

Indications